Navigation Links
Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
Date:3/26/2009

PRINCETON, N.J., March 26 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) today announced that Dr. Geoffrey M. Nichol, Senior Vice President of Product Development at Medarex presented highlights from key programs in Medarex's oncology portfolio at the Needham & Company Cancer Therapeutics: Today & Tomorrow Conference in New York. The archived edition of the presentation webcast is available in the Investor Relations section of the Medarex website at www.medarex.com.

Highlights from Medarex's oncology portfolio included the following:

  • Ipilimumab is a fully human anti-CTLA-4 antibody in development for melanoma, prostate cancer and other cancers. Guidance for the completion of the first-line Phase 3 chemotherapy combination trial in melanoma (study 024) remains unchanged and is expected in late 2009, with overall survival as the primary endpoint under the amended Special Protocol Assessment agreement with the U.S. Food and Drug Administration. Initiation of the second-line Phase 3 radiotherapy combination trial in prostate cancer remains on track for mid-2009. Additional data, including survival and biomarker analyses from the melanoma Phase 2 program and data from the Phase 2 prostate program, will be presented at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO) in May/June.
  • MDX-1105 and MDX-1106 are two fully human antibodies that target the PD-L1/PD-1 pathway for the treatment of cancer. MDX-1105 is in an ongoing multi-dose Phase 1 trial for advanced or recurrent renal cancer, melanoma, non-small cell lung cancer or epithelial cancer. MDX-1106 is in an ongoing multi-dose Phase 1b trial for prostate cancer, melanoma, non-small cell lung cancer and renal cancer. Complete MDX-1106 Phase 1 data will
    '/>"/>

SOURCE Medarex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Medarex Announces 2008 Fourth Quarter and Year End Financial Results
2. Medarex to Announce 2008 Fourth Quarter and Year-End Financial Results on Wednesday, February 25, 2009
3. Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
4. Medarex Reviews Recent Highlights and Outlook for 2009
5. Medarex to Receive Milestone Payment for Approval of STELARA(TM) (Ustekinumab) for the Treatment of Moderate to Severe Plaque Psoriasis
6. Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO
7. Medarex Announces 2008 First Quarter Financial Results
8. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
9. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
10. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , IRVINE, Calif., Dec. 1 /PRN...he inventor of Pulse CO-Oximetry(TM) and Measure-T...day announced FDA clearance of its latest innovati...-- )providing noninvasive and continuous respirati...nd enhances patient compliance. Masimo Rainbow SE...
(Date:12/1/2009)..., Amadeus will operate as... Cedar Knolls, NJ (PRWEB) December 1, 2...has completed the acquisition of all operating ass...er in the development of enterprise governance, ri...utions, from DECIMAL, a corporate performance mana...
(Date:12/1/2009)..., Recent Reviews In Major... One Of The Most Promising New Developments For Th...tive Functioning Difficulties. Some Of The Most Re...(PRWEB) December 1, 2009 -- Review written by: Lee...sorders , Volume 13, No. 3 November 2009. A nice s...
(Date:12/1/2009)..., The Daniel Jordan Fiddl...the mission to develop, advocate for, and support ...ith Autism Spectrum Disorders (ASD), has released ...m, Epilepsy & Seizures: How To Recognize The ... New York, NY (PRWEB) Decembe...
(Date:12/1/2009)..., , EAGAN, Minn., Dec. 1 ...proach to health care for Blue Cross and Blue Shie...ers today, becoming the first Minnesotans - and th...o Online Care Anywhere(SM). Online Care Anywhere a... work simply by logging onto a computer or picking...
Breaking Medicine News(10 mins):Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 2Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 3Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 4Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 5Health News:Masimo Receives FDA Clearance for Masimo Rainbow SET(R) Acoustic Respiration Rate Monitoring 6Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 2Health News:Xybion Acquires Amadeus, a Leader in Governance, Risk, Compliance and Quality Management (GRC) Solutions 3Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 2Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 2Health News:Blue Cross and Blue Shield of Minnesota and Fairview Health Services Launch Online Care Anywhere(TM) 3
... F.A. Davis unveils DavisPTnet...the APTA Combined Sections Meeting. The site featu...ysical therapy continuing education courses (conta... announce the launch of DavisPTnetwork.com, a new ...
...h 24 Is World Tuberculosis Day , , HARRISBURG, P...s today stressed the need to increase public aware... efforts to control, and eventually eliminate, the...hich makes the disease more difficult and costly t...
...LAND HILLS, Calif., March 23 In light of the rece...lla, California-based food safety expert Jeff Nelk...nant women, children and those 55 or older, to tak...foods in terms of food-borne illness. The Center ...
... , WASHINGTON, March 23 Virgil McArthur of Phoen...arch 29 through Tuesday, March 31, 2009 to meet wi...r epilepsy public health programs and more researc...am coordinated by the Epilepsy Foundation and fund...
...ANCHO MIRAGE, Calif. - Breast cancer patients with... fluid in the swollen arm by up to 39 percent afte... as lymphaticovenular bypass, report researchers a...he American Association of Plastic Surgeons, sugge...
... , WASHINGTON, March 23 Alexandria Gray of Chicag...rch 29 through Tuesday, March 31, 2009 to meet wit... epilepsy public health programs and more research...rdinated by the Epilepsy Foundation and funded by ...
Other Medicine News:Health News:New Online Network Features Continuing Education Courses for Physical Therapists 2Health News:Pennsylvania Sees Increase in Tuberculosis, Emphasizing Need for Awareness 2Health News:Food Safety Expert Offers Tips to Be Safe in Wake of Costco & Safeway Egg Recall 2Health News:Arizona Youth Shares Epilepsy Message on Capitol Hill 2Health News:Super micro-surgery offers new hope for breast cancer patients with lymphedema 2Health News:Super micro-surgery offers new hope for breast cancer patients with lymphedema 3Health News:Illinois Youth Shares Epilepsy Message on Capitol Hill 2
(Date:12/1/2009)... /PRNewswire-Asia-FirstCall/ -- China Biologic,Pro...BPO ) ("China Biologic," or,the "Company"), one of...ies in,China, today announced that the Company has... NASDAQ Global Market. , China Biologic e...n,Wednesday, December 2, 2009, until which time it...
(Date:12/1/2009)...swire/ -- Tibotec Therapeutics, a division of Cent... that it is launching a new initiative to raise aw...lor living with HIV/AIDS. Through a comprehensive ... outreach and a new Web site, www.TheGraceStudy.c...CE study, the largest clinical trial in North Amer...
(Date:12/1/2009)...ire/ -- ,, Overweight Children May Develop Bac...m The Children,s Hospital at Montefiore in New Yor...be causing damage to their spines. Researchers rev...etween the ages of 12 and 20 who complained of bac...-year period. The results showed an association be...
Breaking Medicine Technology:China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3How Do Our Attitudes About Beauty Change As We Age 3F 53481 1How Do Our Attitudes About Beauty Change As We Age 3F 53481 2How Do Our Attitudes About Beauty Change As We Age 3F 53481 3How Do Our Attitudes About Beauty Change As We Age 3F 53481 4PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 1PDL BioPharma Elects Barry Selick to Its Board of Directors 53479 2New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records 28EMR 29 Directly at the Point of Care 53477 1New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records 28EMR 29 Directly at the Point of Care 53477 2New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records 28EMR 29 Directly at the Point of Care 53477 3
...NCLUDE JACKSON BROWNE, MORGAN FREEMAN, SAMUEL L. J...DARD, AND FOREST WHITAKER, LOS ANGELES, Oct. 24 ...outh Africa (ANSA) will host "Shaking The Blues," ...les. The evening combines,the power of music and a...l,to the global -- and make a difference in the wo...
...ical trial results suggesting safety and clinical ...CI-EORTC International Conference -, BRANFORD, Co..., a clinical-stage biopharmaceutical company focus...linical trial results on CR011-,vcMMAE, an antibod...atment,of metastatic melanoma, were presented toda...
Other Medicine Technology:Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 2Artists for a New South Africa Will be 'Shaking The Blues' at Gala Benefit November 15, With Performances by Erykah Badu, Nikka Costa, Keb' Mo', Taj Mahal Trio, The Roots, and Guest Stars at The Wiltern in Los Angeles 3CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 2CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 3CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 4CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 5CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 6
Small Joint RAPTOR™ Jr. Punch
Seattle Small Joint Arthroscopy Mallet
ECTRA II System Direct View
AZTEC Shoulder Holder and MITT
Medicine Products: